The in vitro results showed that silencing ANGPT2 significantly decreased the ability of MYBL1-transduced HCC cells to induce HUVEC tube formation and migration (Fig. 5A, B and Supplementary Fig. S3). Here, MYBL1 is linked to hepatocellular carcinoma.